Bio-Rad Laboratories Inc (BIO)

Financial leverage ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Total assets US$ in thousands 12,299,100 11,895,900 11,978,200 13,667,400 13,501,700 12,058,500 12,682,100 14,373,700 17,799,400 19,953,400 15,117,600 13,933,200 12,972,600 12,020,900 10,097,300 8,684,360 8,008,860 7,177,100 7,646,900 6,862,900
Total stockholders’ equity US$ in thousands 8,741,130 8,416,200 8,446,890 9,763,720 9,615,250 8,477,470 8,945,040 10,203,300 13,685,200 15,332,400 11,594,900 10,609,100 9,889,690 8,825,140 7,353,400 6,293,080 5,756,840 5,131,190 5,486,810 4,863,860
Financial leverage ratio 1.41 1.41 1.42 1.40 1.40 1.42 1.42 1.41 1.30 1.30 1.30 1.31 1.31 1.36 1.37 1.38 1.39 1.40 1.39 1.41

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $12,299,100K ÷ $8,741,130K
= 1.41

The financial leverage ratio of Bio-Rad Laboratories Inc. has been relatively stable over the past eight quarters, ranging from 1.40 to 1.43. This indicates that the company relies more on debt financing than equity financing in its capital structure. A financial leverage ratio above 1 suggests that the company has more debt than equity in its capital structure, which can magnify returns on equity but also increases financial risk. Despite minor fluctuations in the ratio, it appears that Bio-Rad Laboratories Inc. has maintained a consistent level of leverage over the observation period. Further analysis could be conducted to assess the impact of the company's leverage on its financial performance and risk profile.